Genes implicated in serotonergic and dopaminergic functioning predict BMI categories

Obesity

Volumn 16, Issue 2, 2008, Pages 348-355

  Fuemmeler, Bernard F ^a   Agurs Collins, Tanya D ^b   McClernon, F Joseph ^a   Kollins, Scott H ^a   Kail, Melanie E ^a   Bergen, Andrew W ^b,c   Ashley Koch, Allison E ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c SRI INTERNATIONAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); DOPAMINE; DOPAMINE 4 RECEPTOR; DOPAMINE TRANSPORTER; DRD4 PROTEIN, HUMAN; SEROTONIN; SEROTONIN TRANSPORTER; SLC6A3 PROTEIN, HUMAN; SLC6A4 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGING; ARTICLE; BODY MASS; CAUCASIAN; COHORT ANALYSIS; COMPARATIVE STUDY; ENERGY METABOLISM; ETHNOLOGY; FEMALE; GENETICS; HISPANIC; HUMAN; LONGITUDINAL STUDY; MALE; METABOLISM; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTION AND FORECASTING; SEXUAL DEVELOPMENT; STATISTICAL MODEL;

ADOLESCENT; ADULT; AGING; BODY MASS INDEX; COHORT STUDIES; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; ENERGY METABOLISM; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MONOAMINE OXIDASE; OBESITY; PREDICTIVE VALUE OF TESTS; RECEPTORS, DOPAMINE D4; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEX CHARACTERISTICS;

EID: 39449136247     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2007.65     Document Type: Article

References (71)

1. Adams KF, Schatzkin A, Harris TB et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 2006;355:763-778.
2. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-1638.
3. Spiegel A, Nabel E, Volkow N, Landis S, U TK. Obesity on the brain. Nat Neurosci 2005;8:552-553.
4. Bray GA. Obesity: the disease. J Med Chem 2006;49:4001-4007.
5. Rice T, Despres JP, Daw EW et al. Familial resemblance for abdominal visceral fat: the HERITAGE family study. Int J Obes Relat Metab Disord 1997;21:1024-1031.
6. Schousboe K, Willemsen G, Kyvik KO et al. Sex differences in heritability of BMI: a comparative study of results from twin studies in eight countries. Twin Res 2003;6:409-421.
7. Stunkard AJ, Harris JR, Pedersen NL, McClearn GE. The body-mass index of twins who have been reared apart. N Engl J Med 1990;322:1483-1487.
8. Rankinen T, Zuberi A, Chagnon YC et al. The human obesity gene map: the 2005 update. Obesity (Silver Spring) 2006;14:529-644.
9. Barsh GS, Schwartz MW. Genetic approaches to studying energy balance: perception and integration. Nat Rev Genet 2002;3:589-600.
10. Small DM, Jones-Gotman M, Dagher A. Feeding-induced dopamine release in dorsal striatum correlates with meal pleasantness ratings in healthy human volunteers. Neuroimage 2003;19:1709-1715.
11. Volkow ND, Wang GJ, Fowler JS et al. "Nonhedonic" food motivation in humans involves dopamine in the dorsal striatum and methylphenidate amplifies this effect. Synapse 2002;44:175-180.
12. Volkow ND, Wang GJ, Maynard L et al. Brain dopamine is associated with eating behaviors in humans. Int J Eat Disord 2003;33:136-142.
13. Wang GJ, Volkow ND, Logan J et al. Brain dopamine and obesity. Lancet 2001;357:354-357.
14. Comings DE, Gade R, MacMurray JP, Muhleman D, Peters WR. Genetic variants of the human obesity (OB) gene: association with body mass index in young women, psychiatric symptoms, and interaction with the dopamine D2 receptor (DRD2) gene. Mol Psychiatry 1996;1:325-335.
15. Noble EP, Noble RE, Ritchie T et al. D2 dopamine receptor gene and obesity. Int J Eat Disord 1994;15:205-217.
16. Spitz MR, Detry MA, Pillow P et al. Variant alleles of the D2 dopamine receptor gene and obesity. Nutrition Research 2000;20:371-380.
17. Thomas GN, Tomlinson B, Critchley JA. Modulation of blood pressure and obesity with the dopamine D2 receptor gene Taql polymorphism. Hypertension 2000;36:177-182.
18. Morton LM, Wang SS, Bergen AW et al. DRD2 genetic variation in relation to smoking and obesity in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Pharmacogenet genomics 2006;16:901-910.
19. Blum K, Braverman ER, Wood RC et al. Increased prevalence of the Taq | A1 allele of the dopamine receptor gene (DRD2) in obesity with comorbid substance use disorder: a preliminary report. Pharmacogenetics 1996;6:297-305.
20. Epstein LH, Jaroni JL, Paluch RA et al. Dopamine transporter genotype as a risk factor for obesity in African-American smokers. Obes Res 2002;10:1232-1240.
21. Jenkinson CP, Hanson R, Cray K et al. Association of dopamine D2 receptor polymorphisms Ser311 Cys and TaqlA with obesity or type 2 diabetes mellitus in Pima Indians. Int J Obes Relat Metab Disord 2000;24:1233-1238.
22. Southon A, Walder K, Sanigorski AM et al. The Taq IA and Ser311 Cys polymorphisms in the dopamine D2 receptor gene and obesity. Diabetes Nutr Metab 2003;16:72-76.
23. Walder K, Segal D, Jowett J, Blangero J, Collier GR. Obesity and diabetes gene discovery approaches. Curr Pharm Des 2003;9:1357-1372.
24. Guo G, North K, Choi S. DRD4 gene variant associated with body mass: the National Longitudinal Study of Adolescent Health. Hum Mutat 2006;27:236-241.
25. Levitan RD, Masellis M, Lam RW et al. Childhood inattention and dysphoria and adult obesity associated with the dopamine D4 receptor gene in overeating women with seasonal affective disorder. Neuropsychopharmacology 2004;29:179-186.
26. Epstein LH, Wright SM, Paluch RA et al. Relation between food reinforcement and dopamine genotypes and its effect on food intake in smokers. Am J Clin Nutr 2004;80:82-88.
27. Lelbowitz SF, Alexander JT Hypothalamic serotonin in control of eating behavior, meal size, and body weight. Biol Psychiatry 1998;44:851-864.
28. Wurtman RJ, Wurtman JJ. Brain Serotonin, Carbohydrate-craving, obesity and depression. Adv Exp Med Biol 1996;398:35-41.
29. Wurtman RJ, Wurtman JJ. Nutrients, neurotransmitter synthesis, and the control of food intake. Res Publ Assoc Res Nerv Ment Dis 1984;62:77-86.
30. Hill AJ, Blundell JE. Sensitivity of the appetite control system in obese subjects to nutritional and serotoninergic challenges. Int J Obes 1990;14:219-233.
31. Wurtman RJ, Wurtman JJ. Brain serotonin, carbohydrate-craving, obesity and depression. Obes Res 1995;3(Suppl 4):S477-S480.
32. Durand E, Boutin P, Meyre D et al. Polymorphisms in the amino acid transporter solute carrier family 6 (neurotransmitter transporter) member 14 gene contribute to polygenic obesity in French Caucasians. Diabetes 2004;53:2483-2486.
33. Suviolahti E, Oksanen U, Ohman M et al. The SLC6A14 gene shows evidence of association with obesity. J Clin Invest 2003;112:1762-1772.
34. Rosmond R, Bouchard C, Bjorntorp R 5-HT2A receptor gene promoter polymorphism in relation to abdominal obesity and cortisol. Obes Res 2002;10:585-589.
35. Rosmond R, Bouchard C, Bjorntorp R Increased abdominal obesity in subjects with a mutation in the 5-HT(2A) receptor gene promoter. Ann NY Acad Sci 2002;967:571-575.
36. Herbeth B, Aubry E, Fumeron F et al. Polymorphism of the 5-HT2A receptor gene and food intakes in children and adolescents: the Stanislas Family Study. Am J Clin Nut 2005;82:467-470.
37. Aubert R, Betoulle D, Herbeth B, Siest G, Fumeron F. 5-HT2A receptor gene polymorphism is associated with food and alcohol intake in obese people. Int J Obes Relat Metab Disord 2000;24:920-924.
38. Santos JL, Ochoa MC, Patino A et al. No evidence of association between the serotonin 2A receptor-1438G/A promoter polymorphism and childhood obesity in a Spanish population: A case-parent study and a matched case-control study. Nutr Neurosci 2005;8:207-211.
39. Sookoian S, Gemma C, Garcia SI et al. Short allele of serotonin transporter gene promoter is a risk factor for obesity in adolescents. Obesity (Silver Spring) 2007;15:271-276.
40. Need AC, Ahmadi KR, Spector TD, Goldstein DB. Obesity is associated with genetic variants that alter dopamine availability. Ann Hum Genet 2006;70:293-303.
41. Camarena B, Santiago H, Aguilar A et al. Family-based association study between the monoamine oxidase A gene and obesity: implications for psychopharmacogenetic studies. Neuropsychobiology 2004;49:126-129.
42. Redden DT, Allison DB. Nonreplication in genetic association studies of obesity and diabetes research. J Nutr 2003;133:3323-3326.
43. Geary N. Is the control of fat ingestion sexually differentiated? Physiol Behav 2004;83:659-671.
44. Hu M, Crombag HS, Robinson TE, Becker JB. Biological basis of sex differences in the propensity to self-administer cocaine. Neuropsychopharmacology 2004;29:81-85.
45. Kang AM, Palmatier MA, Kidd KK. Global variation of a 40-bp VNTR in the 3'-untranslated region of the dopamine transporter gene (SLC6A3). Biol Psychiatry 1999;46:151-160.
46. Williams RB, Marchuk DA, Gadde KM et al. Serotonin-related gene polymorphisms and central nervous system serotonin function. Neuropsychopharmacology 2003;28:533-541.
47. Harris KM, Florey F, Tabor J et al. The National Longitudinal Study of Adolescent Health: Research Design.
48. Resnick MD, Bearman PS, Blum RW et al. Protecting adolescents from harm. Findings from the National Longitudinal Study on Adolescent Health. JAMA 1997;278:823-832.
49. Freeman B, Powell J, Ball D et al. DNA by mail: an inexpensive and noninvasive method for collecting DNA samples from widely dispersed populations. Behav Genet 1997;27:251-257.
50. Lench N, Stanier P, Williamson R. Simple non-invasive method to obtain DNA for gene analysis. Lancet 1988;1:1356-1358.
51. Meulenbelt I, Droog S, Trommelen GJ, Boomsma DI, Slagboom PE. High-yield noninvasive human genomic DNA isolation method for genetic studies in geographically dispersed families and populations. Am J Hum Genet 1995;57:1252-1254.
52. Spitz MR, Shi H, Yang F et al. Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. J Natl Cancer Inst 1998;90:358-363.
53. Anchordoquy HC, McGeary C, Liu L, Krauter KS, Smolen A. Genotyping of three candidate genes after whole-genome preamplification of DNA collected from buccal cells. Behav Genet 2003;33:73-78.
54. Timberlake DS, Haberstick BC, Lessem JM et al. An association between the DAT1 polymorphism and smoking behavior in young adults from the National Longitudinal Study of Adolescent Health. Health Psychol 2006;25:190-197.
55. SUDAAN User's Manual, Release 8.0. 2001; Research Triangle Institute: Research Triangle Park, NC.
56. Todd RD, Huang H, Smalley SL et al. Collaborative analysis of DRD4 and DAT genotypes in population-defined ADHD subtypes. J Child Psychol Psychiatry 2005;46:1067-1073.
57. Munafo M, Clark T, Johnstone E, Murphy M, Walton R. The genetic basis for smoking behavior: a systematic review and meta-analysis. Nicotine Tob Res 2004;6:583-597.
58. Sham PC, Curtis D. Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 1995;59:97-105.
59. Cole TJ, Faith MS, Pietrobelli A, Heo M. What is the best measure of adiposity change in growing children: BMI, BMI %, BMI z-score or BMI centile? Eur J Clin Nutr 2005;59:419-425.
60. Berkey CS, Colditz GA. Adiposity in adolescents: change in actual BMI works better than change in BMI z score for longitudinal studies. Ann Epidemiol 2007;17:44-50.
61. Sookoian S, Gemma C, Garcia SI et al. Short allele of serotonin transporter gene promoter is a risk factor for obesity in adolescents. Obesity (Silver Spring) 2007;15:271-276.
62. Wurtman RJ, Wurtman JJ, Regan MM et al. Effects of normal meals rich in carbohydrates or proteins on plasma tryptophan and tyrosine ratios. Am J Clin Nutr 2003;77:128-132.
63. Lesch KP, Bengel D, Heils A et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region. Science 1996;274:1527-1531.
64. Greenberg BD, Tolliver TJ, Huang SJ et al. Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet 1999;88:83-87.
65. Ducci F, Newman TK, Funt S et al. A functional polymorphism in the MAOA gene promoter (MAOA-LPR) predicts central dopamine function and body mass index. Mol Psychiatry 2006;11:858-866.
66. Gundlah C, Lu NZ, Bethea CL. Ovarian steroid regulation of monoamine oxidase-A and -B mRNAs in the macaque dorsal raphe and hypothalamic nuclei. Psychopharmacology (Berl) 2002;160:271-282.
67. Smith LJ, Henderson JA, Abell CW, Bethea CL. Effects of ovarian steroids and raloxifene on proteins that synthesize, transport, and degrade serotonin in the raphe region of macaques. Neuropsychopharmacology 2004;29:2035-2045.
68. Martel P, Fantino M. Mesolimbic dopaminergic system activity as a function of food reward: a microdialysis study. Pharmacol Biochem Behav 1996;53:221-226.
69. Martel P, Fantino M. Influence of the amount of food ingested on mesolimbic dopaminergic system activity: a microdialysis study. Pharmacol Biochem Behav 1996;55:297-302.
70. Thomas GN, Critchley JA, Tomlinson B, Cockram CS, Chan JC. Relationships between the taql polymorphism of the dopamine D2 receptor and blood pressure in hyperglycaemic and normoglycaemic Chinese subjects. Clin Endocrinol (Oxf) 2001;55:605-611.
71. Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 2003;33:177-182.